2003 Immunization Schedule
"Recommended by the American Academy of Pediatrics"
Regular checkups at your
pediatrician's office or local health clinic are an important way to
keep children healthy.
By making sure that your
child gets immunized on time, you can provide the best available defense
against many dangerous childhood diseases. Immunizations protect
children against: hepatitis B, polio, measles, mumps, rubella (German
measles), pertussis (whooping cough), diphtheria, tetanus (lockjaw),
Haemophilus influenzae type b, pneumococcal infections, and chickenpox.
All of these immunizations need to be given before children are 2 years
old in order for them to be protected during their most vulnerable
period. Are your child's immunizations up-to-date?
The chart below includes
immunization recommendations from the American Academy of Pediatrics.
Remember to keep track of your child's immunizations -- it's the only
way you can be sure your child is up-to-date. Also, check with your
pediatrician or health clinic at each visit to find out if your child
needs any booster shots or if any new vaccines have been recommended
since this schedule was prepared.
If you don't have a
pediatrician, call your local health department. Public health clinics
usually have supplies of vaccine and may give shots free.

1. Hepatitis B vaccine (HepB). All infants should
receive the first dose of hepatitis B vaccine soon after birth and
before hospital discharge; the first dose may also be given by age 2
months if the infant’s mother is HBsAg-negative. Only monovalent HepB
can be used for the birth dose. Monovalent or combination vaccine
containing HepB may be used to complete the series. Four doses of
vaccine may be administered when a birth dose is given. The second dose
should be given at least 4 weeks after the first dose, except for
combination vaccines which cannot be administeredbefore age 6 weeks. The
third dose should be given at least 16 weeks after the first dose and at
least 8 weeks after the second dose. The last dose in the vaccination
series (third or fourth dose) should not be administered before age 6
months.
Infants born to HBsAg-positive mothersshould receive HepB and 0.5 mL
Hepatitis B Immune Globulin (HBIG) within 12 hours of birth at separate
sites. The second dose is recommended at age 1-2 months. The last dose
in the vaccination series should not be administered before age 6
months. These infants should be tested for HBsAg and anti-HBs at 9-15
months of age.Infants born to mothers whose HBsAg status is
unknownshould receive the first dose of the HepB series within 12 hours
of birth. Maternal blood should be drawn as soon as possible to
determine the mother's HBsAg status; if the HBsAg test is positive, the
infant should receive HBIG as soon as possible (no later than age 1
week). The second dose is recommended at age 1-2 months. The last dose
in the vaccination series should not be administered before
age 6 months.
2. Diphtheria and
tetanus toxoids and acellular pertussis vaccine (DTaP). The
fourth dose of DTaP may be administered as early as age 12 months,
provided 6 months have elapsed since the third dose and the child is
unlikely to return at age 15-18 months. Tetanus and diphtheria toxoids (Td)is
recommended at age 11-12 years if at least 5 years have elapsed since
the last dose of tetanus and diphtheria toxoid-containing vaccine.
Subsequent routine Td boosters are recommended every 10years.
3.Haemophilus
influenzaetype b (Hib) conjugate vaccine.Three Hib
conjugate vaccines are licensed for infant use. If PRP-OMP (PedvaxHIB®or
ComVax®[Merck]) is administered at ages 2 and 4 months, a dose at age 6
months is not required. DTaP/Hib combination products should notbe used
for primary immunization in infants at ages 2, 4 or 6 months, but can be
used as boosters following any Hib vaccine.
4. Measles, mumps, and rubella
vaccine (MMR). The second dose of MMR is recommended routinely
at age 4-6 years but may be administered during any visit, provided at
least 4 weeks have elapsed since the first dose and that both doses are
administered beginning at or after age 12 months. Those who have not
previously received the second dose should completethe schedule by the
11-12 year old visit.
5. Varicella vaccine.Varicella
vaccine is recommended at any visit at or after age 12 months for
susceptible children, i.e. those who lack a reliable history of
chickenpox. Susceptible persons aged =13 years should receive two doses,
given at least 4 weeks apart.
6. Pneumococcal vaccine.
The heptavalent pneumococcal conjugatevaccine(PCV)is recommended for all
children age 2-23 months. It is also recommended for certain children
age 24-59 months. Pneumococcal polysaccharide vaccine (PPV)is
recommended in addition to PCV for certain high-risk groups. See
MMWR2000;49(RR-9);1-38.
7. Hepatitis A vaccine.Hepatitis
A vaccine is recommended for children and adolescents in selected states
and regions, and for certain high-risk groups; consult your local public
health authority. Children and adolescents in these states, regions, and
high risk groups who have not been immunized against hepatitis A can
begin the hepatitis A vaccination series during any visit. The two doses
in the series should be administered at least 6 months apart. See
MMWR1999;48(RR-12);1-37.
8. Influenza vaccine. Influenza
vaccine is recommended annually for children age =6 months with certain
risk factors (including but not limited toasthma, cardiac disease,
sickle cell disease, HIV, diabetes, and household members of persons in
groups at high risk; see MMWR 2002;51(RR-3);1-31), and can be
administered to all others wishing to obtain immunity. In addition,
healthy children age 6-23 months are encouraged to receive influenza
vaccine if feasible because children in this age group are at
substantially increased risk for influenza-related hospitalizations.
Children aged =12 years should receive vaccine in a dosage appropriate
for their age (0.25 mL if age 6-35months or 0.5 mL if aged =3 years).
Children aged =8 years who are receiving influenza vaccine for the first
time should receive two doses separated byat least
4 weeks.
For additional
information about vaccines, including precautions and contraindications
for immunization and vaccine shortages, please visit the National
Immunization Program Website at www.cdc.gov/nip
or call the National Immunization Information Hotlineat 800-232-2522
(English) or 800-232-0233 (Spanish).
Approved by the Advisory
Committee on Immunization Practices (www.cdc.gov/nip/acip), the American
Academy of Pediatrics (www.aap.org),
and the American Academy of Family Physicians (www.aafp.org).